These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4190202)

  • 21. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
    Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Essential cryofibrinogenemia. Clinical, pathological and immunological studies.
    Rachmilewitz EA; Sacks MI; Zlotnick A
    Isr J Med Sci; 1970; 6(1):32-43. PubMed ID: 4097374
    [No Abstract]   [Full Text] [Related]  

  • 23. Changes in spontaneous fibrinolytic activity during use of oral contraceptives.
    Hedlin AM; Monkhouse FC
    Obstet Gynecol; 1971 Feb; 37(2):225-32. PubMed ID: 5539358
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cryofibrinogenemia--successful therapy by decreasing fibrinogen].
    Brüning H; Christophers E
    Hautarzt; 1991 Apr; 42(4):227-32. PubMed ID: 1860798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The cryopathies].
    Rønnov-Jessen AD; Birgens HS
    Ugeskr Laeger; 1990 Mar; 152(12):799-803. PubMed ID: 2316034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cryofibrinogenemia].
    Matsuda M
    Nihon Rinsho; 1978 May; Suppl():1638-9. PubMed ID: 691461
    [No Abstract]   [Full Text] [Related]  

  • 27. Congenital afibrinogenemia. Vascular changes and multiple thromboses induced by fibrinogen infusions and contraceptive medication.
    MacKinnon HH; Fekete JF
    Can Med Assoc J; 1971 Apr; 104(7):597-9. PubMed ID: 5550548
    [No Abstract]   [Full Text] [Related]  

  • 28. Progesterone oral contraception and blood coagulation.
    Poller L; Thomson JM; Tabiowo A; Priest CM
    Br Med J; 1969 Mar; 1(5643):554-6. PubMed ID: 4179339
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of oral contraceptive estrogen on blood coagulation and fibrinolysis.
    Hedlin AM
    Thromb Diath Haemorrh; 1975 Apr; 33(2):370-8. PubMed ID: 1138426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Flow properties of blood in women on oral contraceptives (author's transl)].
    Heilmann L; Tauber PF; Siekmann U; Ludwig H
    Zentralbl Gynakol; 1981; 103(12):678-86. PubMed ID: 7282169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated plasma fibrinogen and increased fibrin turnover among healthy women who both smoke and use low-dose oral contraceptives--a preliminary report.
    Scarabin PY; Vissac AM; Kirzin JM; Bourgeat P; Amiral J; Agher R; Guize L
    Thromb Haemost; 1999 Sep; 82(3):1112-6. PubMed ID: 10494773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Internal medicine reflections on hormonal contraception].
    Halhuber C
    Ther Ggw; 1975 Sep; 114(9):1405-25. PubMed ID: 1188696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral contraceptives and the hemostatic system.
    Farag AM; Bottoms SF; Mammen EF; Hosni MA; Ali AA; Moghissi KS
    Obstet Gynecol; 1988 Apr; 71(4):584-8. PubMed ID: 3353050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antithrombin III and fibrinolysis during pregnancy and oral contraceptive therapy].
    Laursen B; Herbst TV; Ewald EC; Pedersen SC
    Ugeskr Laeger; 1976 Feb; 138(6):344-8. PubMed ID: 56073
    [No Abstract]   [Full Text] [Related]  

  • 35. Residual iliofemoral thrombosis in a 31-year-old woman on oral contraceptives possessing heterozygous factor V Leiden, factor XIII Val34Leu allele and alpha-fibrinogen Thr312Ala allele: case report.
    Cieśla-Dul M; Gaweda B; Wypasek E; Rózańska M; Sadowski J
    Pol Arch Med Wewn; 2009 Dec; 119(12):822-5. PubMed ID: 20010469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cryofibrinogenemia as an etiological factor in cerebral thrombophlebitis. Apropos of a case].
    Chazot G; Dumas R; Creyssel R; Girard PF
    Rev Neurol (Paris); 1971 Apr; 124(4):269-75. PubMed ID: 5093985
    [No Abstract]   [Full Text] [Related]  

  • 37. [MUTILATING CRYOPATHY WITH PRESENCE OF CRYOFIBRINOGEN IN THE BLOOD].
    HARMEL-TOURNEUR L; KALIS B
    Bull Soc Fr Dermatol Syphiligr; 1964; 71():663-5. PubMed ID: 14266372
    [No Abstract]   [Full Text] [Related]  

  • 38. Oral contraceptives, blood clotting and thrombosis.
    Poller L
    Br Med Bull; 1978 May; 34(2):151-6. PubMed ID: 350338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. I. CRYOPROTEINEMIAS. 2. PRIMARY CRYOFIBRINOGENEMIA--ITS ASSOCIATION WITH CRYOPATHY AND TELANGIECTASIS.
    RITZMANN SE; LEVIN WC; IVERS JB; KOCH JL
    Tex Rep Biol Med; 1963; 21():567-80. PubMed ID: 14087158
    [No Abstract]   [Full Text] [Related]  

  • 40. Influence of augmented Hageman factor (Factor XII) titers on the cryoactivation of plasma prorenin in women using oral contraceptive agents.
    Gordon EM; Douglas J; Ratnoff OD
    J Clin Invest; 1983 Nov; 72(5):1833-8. PubMed ID: 6355187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.